/OVIT

OVIT Stock - OncoVista Innovative Therapies, Inc.

Q: What is the analyst price target for OVIT?

Analyst price target information is not currently available for OVIT.

Q: What is OVIT's market cap?

Market capitalization information is not currently available for OVIT.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for OVIT

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2010

FY2011

FY2012

FY2013

FY2014

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-45.23

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2014	FY2013	FY2012	FY2011	FY2010
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-2,545,803	$-1,522,190	$-1,981,301	$-2,201,175	$-2,398,481
Net Income	$-2,544,393	$-1,449,613	$-1,628,768	$-2,025,192	$10.10M
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.12	$-0.07	$-0.08	$-0.10	$-0.11

Company Overview

OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.

Visit Website

Frequently Asked Questions about OVIT

What is OVIT's current stock price?

OncoVista Innovative Therapies, Inc. (OVIT) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for OVIT?

No analyst price targets are currently available for this stock.

What sector is OncoVista Innovative Therapies, Inc. in?

OncoVista Innovative Therapies, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is OVIT's market cap?

OncoVista Innovative Therapies, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does OVIT pay dividends?

No, OncoVista Innovative Therapies, Inc. does not currently pay a dividend to shareholders.